Cian Healthcare logo

Cian Healthcare financials and balance sheet

BSE: 542678Pharmaceuticals & BiotechnologySmall Cap

Last close ₹30.36up ₹0.59 (1.98%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹29.77.

52-week range of traded prices to 23 Oct 2026
₹4.72Low, 22 Dec 2025₹30.36High, 23 Oct 2026
Market cap
₹76 Cr4,297th largest listed
P/E
Lossover the last 12 months
P/B
8.9
Dividend yield
Nonein the last 12 months
ROE
−113.9%
Debt to equity
3.36
Volume, BSE
685

8 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Cian Healthcare annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
Peak revenue ₹72 Cr, year to Mar 2021A loss in 4 of the 8 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue28
  2. Depreciation−2.1
  3. Other income+1.2
  4. Finance costs−0.2
  5. Profit before tax−21
  6. Tax−0.1
  7. Net profit−21

What the company owns

  • Plant, investments and other assets₹33 Cr
  • Receivables₹9 Cr
  • Inventory₹5 Cr
  • Cash and bank₹1 Cr

What pays for it: net worth and liabilities

  • Net worth₹21 Cr
  • Borrowings₹14 Cr
  • Other liabilities₹10 Cr
  • Owed to suppliers₹4 Cr

Profit and loss

Standalone, ₹ crore, years to March.Cian Healthcare half-yearly results

₹ croreMar 2019Filed 3 OctMar 2020Filed 1 SepMar 2021Filed 8 JulMar 2022Filed 16 JunMar 2023Filed 1 JunMar 2024Filed 7 AugMar 2025Filed 19 JunMar 2026Filed 30 May
Revenue from operations62.457.072.464.167.658.730.928.3
–49.5–59.259.151.4––
Materials and goods bought45.233.642.938.241.034.020.322.5
Employee costs–4.6–8.28.17.6––
Other expenses–11.3–12.710.19.8––
Operating profit before depreciation–7.5–4.98.57.4––
Operating margin–13.2%–7.7%12.5%12.5%––
Materials, % of revenue–58.9%–59.7%60.6%57.9%––
Employee costs, % of revenue–8.1%–12.8%11.9%12.9%––
Other expenses, % of revenue–19.8%–19.9%14.9%16.6%––
Depreciation and amortisation–2.5–2.63.63.72.62.1
Operating profit after depreciation–5.1–2.44.83.7––
Other income1.00.80.20.50.51.10.31.2
Finance costs5.15.86.25.14.24.72.00.2
Profit before one-off items and tax1.10.10.9−2.31.20.0−7.4−7.6
One-off items–0.0––––––
Profit before tax0.90.10.7−2.41.20.0−19.7−20.9
0.30.10.3−0.10.1−0.40.00.1
Net profit0.7−0.10.3−2.31.10.4−19.7−21.0
Net margin1.0%−0.1%0.5%−3.6%1.6%0.7%−63.6%−74.3%
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2019 and Mar 2021: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2025 and Mar 2026: revenue, other income and exceptional items less the total expenses stated do not come to the profit before tax the same statement states, so the operating expenses cannot be told apart from the rest.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Filed 3 OctMar 2020Filed 1 SepMar 2021Filed 8 JulMar 2022Filed 16 JunMar 2023Filed 1 JunMar 2024Filed 7 AugMar 2025Filed 19 JunMar 2026Filed 30 May
2260606061624221
Share capital1723232525252525
Reserves5363735363717−4
4951504343414014
3349535758569810
252622232125318
Total assets8013513514014114314348
3961777172787631
4173586968656717
Net debt4648474242402213
Borrowings are counted again inside the liabilities due within a year and after a year.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Filed 8 JulMar 2022Filed 16 JunMar 2023Filed 1 JunMar 2024Filed 7 AugMar 2025Filed 19 JunMar 2026Filed 30 May
6.25.52.26.920.720.5
3.15.13.613.726.420.6
−6.10.3−5.25.541.74.1
Receivables1.40.3−5.35.22.86.4
Inventories−6.0−8.3−0.8−2.912.121.0
Payables1.711.1−5.21.58.7−29.9
Other working capital−3.2−2.86.11.618.16.6
Interest paid0.00.00.00.00.00.2
Capital spending0.416.70.20.10.00.0
Free cash flow5.8−11.11.96.820.620.5
−0.4−3.8−1.1−0.9−0.313.4
6.6−2.6−1.2−6.4−3.5−50.3
Dividends paid0.00.00.00.00.00.0
Shares issued0.02.80.00.00.00.0
Net change in cash12.5−1.0−0.1−0.416.9−16.5
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2019Filed 3 OctMar 2020Filed 1 SepMar 2021Filed 8 JulMar 2022Filed 16 JunMar 2023Filed 1 JunMar 2024Filed 7 AugMar 2025Filed 19 JunMar 2026Filed 30 May
Earnings per share₹0.38−₹0.03₹0.14−₹0.96₹0.43₹0.16−₹7.86–
Diluted earnings per share₹0.38−₹0.03₹0.14−₹0.96₹0.43₹0.16−₹7.86–
Book value per share–₹25.49₹25.63₹24.14₹24.57₹24.73₹16.86₹8.24
Shareholder yield––0.0%−5.8%0.0%0.0%0.0%–
Market cap at the year end (₹ crore)–35.026.347.670.051.78.6–
Earnings per share is left blank for the year to Mar 2026: the earnings per share stated does not match any profit the filing states over the shares in issue, and the share count barely moved during the period.

Ratios

Standalone, years to March.Cian Healthcare PE ratio and valuation

RatioMar 2019Filed 3 OctMar 2020Filed 1 SepMar 2021Filed 8 JulMar 2022Filed 16 JunMar 2023Filed 1 JunMar 2024Filed 7 AugMar 2025Filed 19 JunMar 2026Filed 30 May
Revenue growth–−8.6%26.9%−11.4%5.4%−13.0%−47.4%−8.4%
Operating profit growth––––71.6%−13.0%––
Net profit growth–––––−63.8%––
Earnings per share growth–––––−62.8%––
3.0%−0.2%0.5%−3.8%1.8%0.6%−37.8%−67.0%
–−3.2 pts0.7 pts−4.3 pts5.6 pts−1.1 pts−38.4 pts−29.2 pts
From the net margin–−3.4 pts0.8 pts−4.9 pts5.5 pts−1.0 pts−61.3 pts−6.3 pts
From asset turnover–0.1 pts0.0 pts0.6 pts0.1 pts−0.1 pts29.0 pts−16.4 pts
From borrowing–0.1 pts−0.1 pts0.0 pts0.0 pts0.0 pts−6.1 pts−6.5 pts
Return on capital employed–4.6%–2.3%4.6%3.6%––
Cash conversion––1,907.4%–199.8%1,781.7%––
Interest cover–0.9–0.51.20.8––
Debt to equity2.240.860.830.710.700.660.950.66
Receivable days12012893104127114184118
Inventory days12921421932531040446174
Payable days–174––––60964
Cash conversion cycle, days–168––––35128
Working capital days181311170192210209−10280
Asset turnover0.780.530.540.470.480.410.220.30
Assets per rupee of net worth3.682.642.252.282.302.302.753.04
Sales per rupee of plant2.092.751.631.401.561.451.321.29
Capital spending to depreciation–––6.490.070.040.010.00
Plant being built, % of plant in use–119.4%––––––

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
−22.0%
Measure5 years3 years
Revenue growth, yearly rate−17.1%−25.2%
Return on equity, average−21.2%−34.7%
Net margin, average−27.8%−45.8%
Asset turnover, average0.380.31
Cash conversion cycle, days, average–82
Debt to equity, average0.740.76

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations55.748.120.5
Cash from investing7.212.213.4
Cash from financing−64.0−60.2−50.3
Capital spending17.10.20.0
Dividends paid0.00.00.0
Shares issued for cash2.80.00.0
Borrowings repaid26.118.00.0

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Receivables growth less revenue growthOur threshold 0 percentage points–5.41––––––
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–49.25––––––
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–49.92––––––
Effective tax ratePublished threshold 17.16 per cent30.35–––––––
A threshold marked as ours has no published figure; it is the line we read the check against.